Lisa DeFrancesco - Oct 2, 2024 Form 3 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, IR and Corp Strategy
Signature
/s/ Lisa M. DeFrancesco
Stock symbol
LXRX
Transactions as of
Oct 2, 2024
Transactions value $
$0
Form type
3
Date filed
10/7/2024, 04:58 PM
Previous filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LXRX Common Stock 0 Oct 2, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LXRX Stock Option (Right to Buy) Oct 2, 2024 Common Stock 230K $1.01 Direct F1
holding LXRX Restricted Stock Units Oct 2, 2024 Common Stock 74K Direct F2, F3
holding LXRX Stock Option (Right to Buy) Oct 2, 2024 Common Stock 74K $2.15 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (11/13/2024) and vests 1/48th per month for each month of service thereafter.
F2 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.